Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Transferring critically ill babies and children home to die from intensive care.

Morton KE, Richardson A, Coombs MA, Darlington AE.

Nurs Crit Care. 2019 Jul;24(4):222-228. doi: 10.1111/nicc.12410. Epub 2019 Mar 25.

PMID:
30908808
2.

Routine Computer Tomography Imaging for the Detection of Recurrences in High-Risk Melanoma Patients.

Park TS, Phan GQ, Yang JC, Kammula U, Hughes MS, Trebska-McGowan K, Morton KE, White DE, Rosenberg SA, Sherry RM.

Ann Surg Oncol. 2017 Apr;24(4):947-951. doi: 10.1245/s10434-017-5768-8. Epub 2017 Jan 31.

3.

Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma.

Goff SL, Dudley ME, Citrin DE, Somerville RP, Wunderlich JR, Danforth DN, Zlott DA, Yang JC, Sherry RM, Kammula US, Klebanoff CA, Hughes MS, Restifo NP, Langhan MM, Shelton TE, Lu L, Kwong ML, Ilyas S, Klemen ND, Payabyab EC, Morton KE, Toomey MA, Steinberg SM, White DE, Rosenberg SA.

J Clin Oncol. 2016 Jul 10;34(20):2389-97. doi: 10.1200/JCO.2016.66.7220. Epub 2016 May 23.

4.

Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor.

Kochenderfer JN, Dudley ME, Kassim SH, Somerville RP, Carpenter RO, Stetler-Stevenson M, Yang JC, Phan GQ, Hughes MS, Sherry RM, Raffeld M, Feldman S, Lu L, Li YF, Ngo LT, Goy A, Feldman T, Spaner DE, Wang ML, Chen CC, Kranick SM, Nath A, Nathan DA, Morton KE, Toomey MA, Rosenberg SA.

J Clin Oncol. 2015 Feb 20;33(6):540-9. doi: 10.1200/JCO.2014.56.2025. Epub 2014 Aug 25.

5.

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy.

Rosenberg SA, Yang JC, Sherry RM, Kammula US, Hughes MS, Phan GQ, Citrin DE, Restifo NP, Robbins PF, Wunderlich JR, Morton KE, Laurencot CM, Steinberg SM, White DE, Dudley ME.

Clin Cancer Res. 2011 Jul 1;17(13):4550-7. doi: 10.1158/1078-0432.CCR-11-0116. Epub 2011 Apr 15.

6.

CD8+ enriched "young" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma.

Dudley ME, Gross CA, Langhan MM, Garcia MR, Sherry RM, Yang JC, Phan GQ, Kammula US, Hughes MS, Citrin DE, Restifo NP, Wunderlich JR, Prieto PA, Hong JJ, Langan RC, Zlott DA, Morton KE, White DE, Laurencot CM, Rosenberg SA.

Clin Cancer Res. 2010 Dec 15;16(24):6122-31. doi: 10.1158/1078-0432.CCR-10-1297. Epub 2010 Jul 28.

7.

Different adjuvanticity of incomplete freund's adjuvant derived from beef or vegetable components in melanoma patients immunized with a peptide vaccine.

Rosenberg SA, Yang JC, Kammula US, Hughes MS, Restifo NP, Schwarz SL, Morton KE, Laurencot CM, Sherry RM.

J Immunother. 2010 Jul-Aug;33(6):626-9. doi: 10.1097/CJI.0b013e3181dac9de.

8.

IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells.

Rosenberg SA, Sport├Ęs C, Ahmadzadeh M, Fry TJ, Ngo LT, Schwarz SL, Stetler-Stevenson M, Morton KE, Mavroukakis SA, Morre M, Buffet R, Mackall CL, Gress RE.

J Immunother. 2006 May-Jun;29(3):313-9.

9.

Altered CD8(+) T-cell responses when immunizing with multiepitope peptide vaccines.

Rosenberg SA, Sherry RM, Morton KE, Yang JC, Topalian SL, Royal RE, Kammula US, Restifo NP, Hughes MS, Schwarz SL, Ngo LT, Mavroukakis SA, White DE.

J Immunother. 2006 Mar-Apr;29(2):224-31.

10.

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma.

Rosenberg SA, Sherry RM, Morton KE, Scharfman WJ, Yang JC, Topalian SL, Royal RE, Kammula U, Restifo NP, Hughes MS, Schwartzentruber D, Berman DM, Schwarz SL, Ngo LT, Mavroukakis SA, White DE, Steinberg SM.

J Immunol. 2005 Nov 1;175(9):6169-76.

11.

Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer.

Yang JC, Sherry RM, Steinberg SM, Topalian SL, Schwartzentruber DJ, Hwu P, Seipp CA, Rogers-Freezer L, Morton KE, White DE, Liewehr DJ, Merino MJ, Rosenberg SA.

J Clin Oncol. 2003 Aug 15;21(16):3127-32.

12.

Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma.

Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Topalian SL, Sherry RM, Restifo NP, Wunderlich JR, Seipp CA, Rogers-Freezer L, Morton KE, Mavroukakis SA, Gritz L, Panicali DL, White DE.

Clin Cancer Res. 2003 Aug 1;9(8):2973-80.

13.

Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens.

Phan GQ, Touloukian CE, Yang JC, Restifo NP, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, Seipp CA, Freezer LJ, Morton KE, Mavroukakis SA, White DE, Rosenberg SA.

J Immunother. 2003 Jul-Aug;26(4):349-56.

14.

Sexual offender recidivism risk: what we know and what we need to know.

Hanson RK, Morton KE, Harris AJ.

Ann N Y Acad Sci. 2003 Jun;989:154-66; discussion 236-46.

PMID:
12839896
15.

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma.

Phan GQ, Yang JC, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, Restifo NP, Haworth LR, Seipp CA, Freezer LJ, Morton KE, Mavroukakis SA, Duray PH, Steinberg SM, Allison JP, Davis TA, Rosenberg SA.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8372-7. Epub 2003 Jun 25.

16.

Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen.

Rosenberg SA, Yang JC, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, Restifo NP, Haworth LR, Seipp CA, Freezer LJ, Morton KE, Mavroukakis SA, White DE.

Hum Gene Ther. 2003 May 20;14(8):709-14.

17.

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.

Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ, Topalian SL, Sherry R, Restifo NP, Hubicki AM, Robinson MR, Raffeld M, Duray P, Seipp CA, Rogers-Freezer L, Morton KE, Mavroukakis SA, White DE, Rosenberg SA.

Science. 2002 Oct 25;298(5594):850-4. Epub 2002 Sep 19.

18.

A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma.

Dudley ME, Wunderlich JR, Yang JC, Hwu P, Schwartzentruber DJ, Topalian SL, Sherry RM, Marincola FM, Leitman SF, Seipp CA, Rogers-Freezer L, Morton KE, Nahvi A, Mavroukakis SA, White DE, Rosenberg SA.

J Immunother. 2002 May-Jun;25(3):243-51.

19.

Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma.

Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ, Sherry RM, Topalian SL, Yang JC, Stock F, Freezer LJ, Morton KE, Seipp C, Haworth L, Mavroukakis S, White D, MacDonald S, Mao J, Sznol M, Rosenberg SA.

J Clin Oncol. 2002 Jan 1;20(1):142-52.

20.

A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Nystatin on the Development of Oral Irritation in Patients Receiving High-Dose Intravenous Interleukin-2.

Ohnmacht GA, Phan GQ, Mavroukakis SA, Steinberg SM, Shea YR, Witebsky FG, McIntyre LS, Goodwin RS, Muehlbauer PM, Morton KE, Rogers-Freezer LJ, Seipp CA, Rosenberg SA, Marincola FM.

J Immunother (1991). 2001 Mar;24(2):188-192.

PMID:
11449076
21.

A prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patients receiving high-dose intravenous interleukin-2.

Ohnmacht GA, Phan GQ, Mavroukakis SA, Steinberg SM, Shea YR, Witebsky FG, McIntyre LS, Goodwin RS, Muehlbauer PM, Morton KE, Rogers-Freezer LJ, Seipp CA, Rosenberg SA, Marincola FM.

J Immunother. 2001 Mar-Apr;24(2):188-92.

PMID:
11265777
22.

Fatal neonatal subdural haemorrhage following normal vaginal delivery.

Butler-Manuel SA, Morley-Jacobs C, Morton KE.

J Obstet Gynaecol. 1997 Nov;17(6):584. No abstract available.

PMID:
15511967
23.

Fluid management during labour: a British view.

Morton KE.

Int J Obstet Anesth. 1993;2(3):147-51. No abstract available.

PMID:
15636876
24.

A study of 100 high risk lupus pregnancies.

Buchanan NM, Khamashta MA, Morton KE, Kerslake S, Baguley EA, Hughes GR.

Am J Reprod Immunol. 1992 Oct-Dec;28(3-4):192-4. Review.

PMID:
1285876
25.

Early Doppler studies in lupus pregnancy.

Kerslake S, Morton KE, Versi E, Buchanan NM, Khamashta M, Baguley E, Braude P, Hughes GR.

Am J Reprod Immunol. 1992 Oct-Dec;28(3-4):172-5.

PMID:
1285872
26.

The role of ultrasound in gynecological emergencies.

Mould TA, Byrne DL, Morton KE.

Ultrasound Obstet Gynecol. 1992 Mar 1;2(2):121-3.

27.

The aetiology of vaginal bleeding in children. A 20-year review.

Hill NC, Oppenheimer LW, Morton KE.

Br J Obstet Gynaecol. 1989 Apr;96(4):467-70.

PMID:
2751960
28.

Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumour, including pre-operative bromocriptine therapy.

Bevan JS, Adams CB, Burke CW, Morton KE, Molyneux AJ, Moore RA, Esiri MM.

Clin Endocrinol (Oxf). 1987 May;26(5):541-56.

PMID:
3665118
29.

Coronary artery bypass graft failure--an autoimmune phenomenon?

Morton KE, Gavaghan TP, Krilis SA, Daggard GE, Baron DW, Hickie JB, Chesterman CN.

Lancet. 1986 Dec 13;2(8520):1353-7. Erratum in: Lancet 1987 Oct 24;2(8565):977-8.

PMID:
2878224
30.

The use of the fasciocutaneous flap in vaginal reconstruction.

Morton KE, Davies D, Dewhurst J.

Br J Obstet Gynaecol. 1986 Sep;93(9):970-3.

PMID:
3768290
31.

A narrow escape for the second of mono-amniotic twins.

Morton KE, Reid W.

J Obstet Gynaecol. 1986 Jul;7(1):53-54. doi: 10.1080/01443615.1986.11978615. No abstract available.

PMID:
29480122
32.

Intrapartum fetal monitoring-is the scalp electrode necessary?

Morton KE.

J Obstet Gynaecol. 1986 Jul;7(1):32-34. doi: 10.1080/01443615.1986.11978606. No abstract available.

PMID:
29480109
33.

Vaginoplasty using amnion.

Ashworth MF, Morton KE, Dewhurst J, Lilford RJ, Bates RG.

Obstet Gynecol. 1986 Mar;67(3):443-6.

PMID:
3945456
34.

Human amnion in the treatment of vaginal malformations.

Morton KE, Dewhurst CJ.

Br J Obstet Gynaecol. 1986 Jan;93(1):50-4.

PMID:
3942707
35.

A comparison of the effects of four intravenous solutions for the treatment of ketonuria during labour.

Morton KE, Jackson MC, Gillmer MD.

Br J Obstet Gynaecol. 1985 May;92(5):473-9.

PMID:
3994929
36.

Ontogeny and neonatology of circulating endogenous inhibitor(s) of prostaglandin synthase in the human.

Brennecke SP, Kirkham FJ, Morton KE, MacKenzie IZ, Wilkinson AR, Mitchell MD.

Biol Neonate. 1984;46(1):1-9.

PMID:
6430356

Supplemental Content

Loading ...
Support Center